ARYL UREAS WITH RAF KINASE AND ANGIOGENESIS INHIBITING ACTIVITY

摘要

This invention relates to methods of using aryl ureas to treat diseases mediated by raf kinase and diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.